NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Dermatology/Pretibial Myxedema in Graves Disease
    Pretibial Myxedema in Graves Disease
    medium
    hand Dermatology

    A 42-year-old woman with Graves disease (TSI-positive, treated with carbimazole and now on levothyroxine after thyroidectomy) presents with bilateral, non-pitting, indurated, waxy plaques on the anterolateral shins with a characteristic peau d'orange surface and prominent follicular ostia. She also has bilateral proptosis and digital clubbing. The structure marked **B** in the diagram shows the characteristic skin manifestation. Which of the following best describes the pathophysiology underlying this lesion?

    A. Immune-mediated collagen necrosis with lipid deposition in the dermis, associated with diabetes mellitus
    B. Deposition of glycosaminoglycans (hyaluronic acid) in the dermis driven by TSH-receptor antibodies cross-reacting with dermal fibroblasts
    C. Chronic inflammation with lichenification secondary to repeated scratching and impaired venous return
    D. Chronic venous insuffocation leading to lipodermatosclerosis and dermal fibrosis

    Explanation

    Why option 1 is correct

    The structure marked B represents pretibial myxedema (thyroid dermopathy), an infiltrative dermopathy pathognomonic to Graves disease. The hallmark pathophysiology is glycosaminoglycan (predominantly hyaluronic acid) deposition in the dermis, driven by TSH-receptor antibodies (TRAb) that cross-react with fibroblasts in dermal connective tissue. Histologically, this produces widely separated collagen bundles with mucin deposition in the mid-to-deep dermis, staining positive with colloidal iron or Alcian blue. This occurs in 1–5% of Graves disease patients, almost always with concurrent ophthalmopathy and high TRAb titers, and can paradoxically appear after biochemical euthyroidism is achieved (Bolognia Dermatology 5e; Endocrine Reviews on Graves Orbitopathy 2024).

    Why each distractor is wrong

    • Option 2 (Chronic venous insufficiency): This describes lipodermatosclerosis (marked A in the diagram), not thyroid dermopathy. Venous insufficiency produces fibrosis and hemosiderin deposition, not glycosaminoglycan accumulation, and is not associated with Graves disease or TSI positivity.
    • Option 3 (Collagen necrosis with lipid deposition): This describes necrobiosis lipoidica diabeticorum (marked C in the diagram), a diabetic dermopathy characterized by immune-mediated collagen necrosis and lipid deposition. It is not driven by TSH-receptor antibodies and is not a feature of Graves disease.
    • Option 4 (Lichenification from scratching): This describes stasis dermatitis with secondary lichen simplex chronicus (marked D in the diagram), a consequence of chronic venous insufficiency and repeated trauma. It lacks the characteristic glycosaminoglycan deposition and TSI-mediated pathophysiology of thyroid dermopathy.
    High-YieldNEET PG
    Pretibial myxedema is a TSI-driven infiltrative dermopathy with hyaluronic acid deposition; it occurs in ~1–5% of Graves disease, almost always with ophthalmopathy, and can appear even after euthyroidism is restored.

    Bolognia Dermatology 5e; Endocrine Reviews on Graves Orbitopathy 2024

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Dermatology Questions